KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Calumet (CLMT) Cash & Equivalents (2022 - 2025)

Calumet (CLMT) has disclosed Cash & Equivalents for 4 consecutive years, with $125.1 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 228.35% to $125.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $125.1 million through Dec 2025, up 228.35% year-over-year, with the annual reading at $125.1 million for FY2025, 228.35% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $125.1 million at Calumet, up from $94.6 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $125.1 million in Q4 2025, with the low at $7.0 million in Q2 2024.
  • Average Cash & Equivalents over 4 years is $54.7 million, with a median of $36.6 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents plummeted 83.57% in 2024, then surged 1480.0% in 2025.
  • Over 4 years, Cash & Equivalents stood at $35.2 million in 2022, then plummeted by 77.56% to $7.9 million in 2023, then soared by 382.28% to $38.1 million in 2024, then skyrocketed by 228.35% to $125.1 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $125.1 million, $94.6 million, and $110.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.